EW -
Edwards Lifesciences Corp
| Day |
1m |
10m |
60m |
PreMarket |
Market |
AfterHours |
Gap |
| 84.38 0.71 (0.84%) |
-0.05 (-0.06%) |
-0.1 (-0.12%) |
-0.31 (-0.37%) |
--- |
0.71 (0.84%) |
--- |
--- |
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Earnings & Ratios
- Basic EPS:
- 0.57
- Diluted EPS:
- 0.56
- Basic P/E:
- 149.2807
- Diluted P/E:
- 151.9464
- RSI(14) 1m:
- 58.16
- VWAP:
- 85.13
- RVol:
Events
| Period |
Kind |
Movement |
Occurred At |
Related News
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
Oct 28, 2025 00:44
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
Oct 24, 2025 19:56
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
Oct 21, 2025 20:00
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
Oct 15, 2025 21:58
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
Oct 11, 2025 16:18
EW 投資者消息:若您因 Edwards Lifesciences Corporation (NYSE: EW) 蒙受損失,請聯絡 Rosen Law Firm 了解您的權益
Oct 03, 2025 16:16
EW Investor News: If You Have Suffered Losses in Edwards Lifesciences Corporation (NYSE: EW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Oct 02, 2025 19:45
EW Investor News: If You Have Suffered Losses in Edwards Lifesciences Corporation (NYSE: EW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Sep 26, 2025 23:04
JenaValve Announced ESC Guidelines Recognize TAVI as Class IIb Recommendation for Aortic Regurgitation
Sep 10, 2025 12:00
Picard Announces Appointment of Two New Members to its Board of Directors
Sep 10, 2025 12:00